soluble IL-13 receptor modulators(Wyeth BioPharma)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Namesoluble IL-13 receptor modulators(Wyeth BioPharma)
Drug Alias NamesIL-13R (Genetics Institute)sIL-13R (Wyeth BioPharma)soluble IL-13 receptor modulators(Genetics Institute)sIL-13R
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionInterleukin 13 receptor modulators
TargetsInterleukin 13 receptor
Therapy Area/IndicationsAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesWyeth BioPharma
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesWyeth BioPharma
Active IndicationsN/A
Inactive IndicationsAsthma

Other Information

ATC CodeN/A
Related LinksN/A